Brief: CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome

CohBar

09/12/2020 14:07

Dec 9 (Reuters) - CohBar Inc  CWBR.O :
    * COHBAR - ANNOUNCED NEW PRECLINICAL DATA CONFIRMING
EFFICACY OF
APELIN AGONIST PEPTIDES IN A PRECLINICAL MODEL OF ACUTE
RESPIRATORY DISTRESS SYNDROME
    * COHBAR INC - EXPECTS APELIN AGONISTS TO HAVE POTENTIAL TO
TREAT
COVID-19 ASSOCIATED ARDS AS WELL AS ARDS PATIENTS IN GENERAL

Source text for Eikon:  ID:nGNXbSPKxQ 
Further company coverage:  CWBR.O 

 ((Reuters.Briefs@thomsonreuters.com;))